Dr. Martin Langer

Executive Vice President,
Head Industrial BioSolutions
Business Unit

Dr. Martin Langer, born in 1965, is a biochemist and molecular biologist by training. He studied biology at Technische Universität Darmstadt, Germany, Adelaide University, Australia and Karlsruhe University, Germany. For his doctoral thesis, which he pursued at Karlsruhe University, he worked on enzymes with rare prosthetic groups and analyzed the catalytic behavior of these biocatalysts.Since 1995 Dr. Langer has been working with BRAIN, where he started as a project manager. Between 1999 and 2005 he worked for the pharmaceutical biotech spin off of BRAIN, named VISCUM. Here he was the head of Business Development and besides identifying of external collaboration partners also responsible for identification and planning of venture capital funding. During 1999 and 2003 he was also member of the supervisory board of VISCUM.

In June 2005, Dr. Langer took charge of the Corporate Development Unit at BRAIN. In this role, he shared responsibility for corporate development with BRAIN’s CEO, a portfolio which also included the conception, implementation and coordination of the “NatLifE 2020” strategic alliance, for instance. In January 2013 he was appointed to BRAIN’s executive committee and has held responsibility for the Industrial BioSolutions Business Unit, which among others covers the Green & Urban Mining Business Areas, since December 2018. Dr. Langer is a member of the German section of the Pharma Licensing Club and represents BRAIN in the IWBio e.V. German Industrial Biotechnology Association.

Share this page